News
Startup Persist AI, which launched a cloud lab to accelerate pharmaceutical formulation development, raised $12 million in a ...
23h
24/7 Wall St. on MSN3 Overlooked Dividend Growers With 10%+ Annual Dividend IncreasesInvestors usually focus on stocks that already have stellar dividend yields, but your portfolio could also benefit from ...
22h
GlobalData on MSNSanofi buys Vigil Neuroscience for $470m in Alzheimer’s pushPart of the deal also includes an additional $2 cash payment per share upon the first commercial sale of Vigil’s Alzheimer’s ...
Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...
Manufacturers have lined up to announce expansions even as Trump trade policy led to disappointing Q1 results and predictions ...
President Donald Trump has touted multi-trillion-dollar investment commitments as proof that his economic strategy is ...
1h
Zacks Investment Research on MSNQGEN Stock Might Gain Following New Partnership With ID SolutionsQIAGEN N.V. QGEN recently entered into a commercial partnership and co-marketing agreement with ID Solutions, a French provider of high-quality digital PCR (dPCR) assays, to expand the availability of ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
The global sales of peptide therapeutics is estimated to be worth USD 42.1 billion in 2024 and anticipated to reach a value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results